Approval · Notice of Compliance 25229 · 2021
EXPERIOR 50: Notice of Compliance 25229
Issued February 17, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25229
- Date
- February 17, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Strength
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXPERIOR 50 | 02512610 | Approved |
Medicinal ingredients
- LUBABEGRON 50 G per KG